AANS Neurosurgeon | Volume 26, Number 4, 2017


Old Drug Could Fight Brain Cancer by Starving It to Death

New research targets the most common form of deadly brain cancer, glioblastoma. Currently, there is no cure for this type of tumor. However, this study aims to shut down the sugar availability to the cancer cells in hopes of inhibiting further tumor growth. What makes glioblastoma cells so interesting is their ability to reprogram their metabolism to rely on a high uptake of glucose to sustain the cells’ malignant activity. By using a drug known as flavopirid that inactivates the enzyme glycogen phosphorylase, these researchers think they could cut the tumor cells off at the source so to speak. “This points toward a new possible use of this compound of flavopiridol-derived formulations in combination with anti-proliferative agents in glioblastoma patients.” To read more, click here.


Winter Clinics for Cranial and Spinal Surgery
Feb. 25, 2018 - Mar. 1, 2018; Snowmass Village, Colo.

69th Southern Neurosurgical Society Annual Meeting
Feb. 28, 2018 - Mar. 3, 2018; San Juan, PR

Second International Brain Mapping Course
April 26-27, 2018; New Orleans

Comments are closed.